Subchronic nasal toxicity of hexamethylphosphoramide administered to rats orally for 90 days

Fundamental and Applied Toxicology

Volumn 40, Issue 1, 1997, Pages 15-29

  Keller, Douglas A ^a   Marshall, Craig E ^a   Lee, K P ^a  

^a DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMPA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG TOXICITY; FACIAL BONE; FEMALE; HISTOLOGY; HISTOPATHOLOGY; LUNG ALVEOLUS EPITHELIUM; MALE; NONHUMAN; NOSE CAVITY; NOSE MUCOSA; NOSE SEPTUM; ORAL DRUG ADMINISTRATION; OSMOTIC MINIPUMP; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TESTIS ATROPHY; TISSUE INJURY; TRACHEA;

ANIMALIA;

EID: 26844431644     PISSN: 02720590     EISSN: None     Source Type: Journal    
DOI: 10.1006/faat.1997.2375     Document Type: Article

References (41)

1. Amacher D. E., Turner G. N. Tests for gene mutational activity in the L5178Y/TK assay system. Prog. Mutat. Res. 5:1985;487-496.
2. Ashby J., Richardson C. R., Lefevre P. A., Callander R. D., Styles J. A. Chloracetamide-N. Mutat. Res. 156:1985a;19-32.
3. Ashby J., Callendar R. D., Rose F. L. Weak mutagenicity to Salmonella of the formaldehyde-releasing anti-tumor agent hexamethylmelamine. Mutat. Res. 142:1985b;121-125.
4. Bab I., Gazit D., Muhlrad A., Shteyre A. Regenerating bone marrow produces a potent growth-promoting activity to osteogenic cells. Endocrinology. 113:1988;345-352.
5. Bogdanffy M. S. Biotransformation enzymes in the rodent nasal mucosa: The value of a histochemical approach. Environ. Health. Perspect. 85:1990;177-186.
6. Belinsky S. A., Walker V. E., Maronopot R. R., Swenberg J. A., Anderson M. W. Molecular dosimetry and DNA adduct formation and cell toxicity in rat nasal mucosa following exposure to the tobacco specific nitrosamine 4-(N-methyl-N-nitrosoamino)-1-(3-pyridyl)-1-butanone and their relationship to induction of neoplasia. Cancer Res. 47:1987;6058-6065.
7. Brittebo E. V., Erksson C., Brandt I. Activation and toxicity of bromobenzene in nasal tissues in mice. Arch. Toxicol. 64:1990;54-60.
8. Canalis E., Lian J. B. Effects of bone associated growth factors on DNA, collagen and osteoclasin synthesis in cultured fetal rat calvariae. Bone. 9:1988;243-246.
9. +. Biochem. Pharmacol. 33:1984;1137-1142.
10. Dahl A. R., Hadley W. M., Hahn F. F., Benson J. M., McClellan R. O. Cytochrome P-450-dependent monooxygenases in olfactory epithelium of dogs: Possible role in tumorigenicity. Science. 216:1982;57-59.
11. Dahl A. R., Hadley W. M. Nasal cavity enzymes involved in xenobiotic metabolism: Effects on the toxicity of inhalants. Crit. Rev. Toxicol. 21:1991;345-372.
12. Dunnett C. W. Multiple comparison procedure for comparing several treatment with a control. J. Am. Stat. Assoc. 55:1955;1096-1121.
13. Dunnett C. W. New tables for multiple comparison with a control. Biometrics. 20:1964;482-491.
14. Goldsworthy T. L., Monticello T. M., Jackh R., Smith-Oliver T., Bermudez E., Morgan K. T., Butterworth B. E. Assessment of 1,4-dioxane-induced carcinogenicity, genotoxicity and cell replication in rat nose and liver. Proc. Am. Assoc. Cancer Res. 29:1988;85.
15. Hadley W. M., Dahl A. R. Cytochrome P-450 dependent monooxygenase activity in rat nasal epithelial membranes. Toxicol. Lett. 10:1982;417-422.
16. Heck H. d'A., Casanova-Schmitz M. Biochemical toxicology of formaldehyde. Rev. Biochem. Toxicol. 6:1984;155-189.
17. Hunstein W. Experimental myelofibrosis. Clin. Haematol. 4:1975;457-478.
18. Jones A. R., Jackson H. The metabolism of hexamethylphosphoramide and related compounds. Biochem. Pharmacol. 17:1968;2247-2252.
19. Kerns W. D., Pavkov K. L., Donofrio D. J., Gralla E. J., Swenberg J. A. Carcinogenicity of formaldehyde in rats and mice after long-term inhalation exposure. Cancer Res. 43:1983;4382-4392.
20. Kimbrough R., Sedlack V. A. Lung morphology in rats treated with hexamethylphosphoramide. Toxicol. Appl. Pharmacol. 12:1968;60-67.
21. Kimbrough R., Gaines T. B. The chronic toxicity of hexamethylphosphoramide in rats. Bull. Environ. Contam. Toxicol. 10:1973;225-226.
22. Kociba R. J., McCollister S. B., Park C., Toreklson T. R. 1,4-Dioxane, I. Results of a two-year ingestion study in rats. Toxicol. Appl. Pharmacol. 30:1974;275-286.
23. Kuykendall J. R., Trela B. A., Bogdanffy M. S. DNA-protein crosslink formation in rat nasal epithelial cells by hexamethylphosphoramide and its correlation with formaldehyde production. Mutat. Res. 343:1995;209-218.
24. 1. Fundam. Appl. Toxicol. 22:1994;431-446.
25. Lee K. P., Trochimowicz H. J. Induction of nasal tumors in rats exposed to hexamethylphosphoramide by inhalation. J. Natl. Cancer Inst. 68:1982a;157-171.
26. Lee K. P., Trochimowicz H. J. Metaplastic changes of nasal respiratory epithelium in rats exposed to hexamethylphosphoramide (HMPA) by inhalation. Am. J. Pathol. 106:1982b;8-12.
27. Longo V., Citti L., Gervsai P. G. Metabolism of diethylnitrosamine by nasal mucosa and hepatic microsomes from hamster and rat: Species specificity of nasal mucosa. Carcinogenesis. 7:1986;1323-1328.
28. Monticello T. M., Morgan K. T. Nasal lesion distribution and toxicity in the squamous epithelial region. Inhalation Toxicol. 6:1994;177-186.
29. Morgan K. T. Nasal dosimetry, lesion distribution, and the toxicologic pathologist: A brief review. Inhalation Toxicol. 6:1994;41-57.
30. Morris J. B. Upper respiratory tract metabolism of inspired alcohol dehydrogenase and mixed function oxidase substrate vapors under defined airflow conditions. Inhal. Toxicol. 5:1993;203-222.
31. NIOSH (National Institute for Occupational Safety and Health), 1975, Background Information on Hexamethylphosphoric Triamide, US Department of Health, Education and Welfare, Rockville, MD.
32. Overcash R. D., Lindsey J. R., Cassell G. H., Baker H. J. Enhancement of chronic murine pneumonia in the rats by oral hexamethylphosphoramide. Am. J. Pathol. 82:1971;171-190.
33. Rickard R. W., Gillies P. J. Hexamethylphosphoramide (HMPA) nasal carcinogenesis: Selective retention of 14C-HMPA radioactivity in target tissues and its inhibition by metyrapone. Toxicologist. 2:1982;162.
34. Rickard R. W., Quarles J. P. The disposition of hexamethylphosphoramide (HMPA) in rats following various routes of administration. Toxicologist. 1:1981;125.
35. Shott L. D., Bokovec A. B., Knapp W. A. Jr. Toxicology of hexamethylphosphoramide in rats and rabbits. Toxicol. Appl. Pharmacol. 18:1971;499-506.
36. Snedcor G. W., Cochran W. G. Statistical Methods. 1980;Iowa State Univ. Press, Ames. p. 234-.
37. Stashenko P., Obernesser M. S., Dewhirst F. E. Effect of immune cytokines on bone. Immunol. Invest. 18:1989;239-245.
38. Sun J. D., Dahl A. R., Gillett N. A., Barr E. B., Crews M. L., Edison A. F., Bechtold W. E., Burt D. G., Dieter M. P., Hobbs C. H. Two-week repeated inhalation exposure of F344/N rats and B6C3F1 mice to ferrocene. Fundam. Appl. Toxicol. 17:1991;150-158.
39. Trela B. A., Bogdanffy M. S. Carboxylesterase-dependent cytotoxicity of dibasic esters (DBE) in rat nasal explants. Toxicol. Appl. Pharmacol. 107:1991;285-301.
40. Turk M. A. M., Henk W. G., Flory W. 3-Methylindole-induced nasal mucosal damage in mice. Vet. Pathol. 24:1987;400-403.
41. Zijlstra J. A., Brussee J., van der Gen A., Vogel E. W. Importance of multiple hydroxylated metabolites in hexamethylphosphoramide (HMPA)-mediated mutagenesis inDrosophila melanogaster. Mutat. Res. 212:1989;193-211.